Fingerprint
Dive into the research topics of 'Vision in a phase 3 trial of natalizumab for multiple sclerosis: Relation to disability and quality of life'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vision in a phase 3 trial of natalizumab for multiple sclerosis: Relation to disability and quality of life
Salim Chahin, Laura J. Balcer, Deborah M. Miller, Annie Zhang, Steven L. Galetta
Research output: Contribution to journal › Article › peer-review
15
Scopus
citations